期刊文献+

基于“伏邪”说的肝复安治疗慢性乙型病毒性肝炎患者铁代谢异常临床观察 被引量:5

Clinical observation of the effects of “Ganfuan Decoction” on the iron metabolism dysregulation in chronic viral hepatitis B patients based on Fuxie theory
下载PDF
导出
摘要 目的观察基于"伏邪"说的肝复安治疗慢性乙型病毒性肝炎(简称慢乙肝)患者铁代谢异常的临床疗效。方法将102例铁代谢异常相关性肝病(慢乙肝及肝硬化)患者分为治疗组(48例)与对照组(54例)。治疗组予中药"肝复安"辨证治疗,对照组予西医常规药物(抗病毒、保肝药)治疗。两组疗程均为36个月,观察肝脏铁质沉积疗效,比较血清铁代谢指标、肝功能、病毒及相关免疫指标等的变化情况。结果 1组间肝脏铁沉积疗效比较,第24个月、第36个月差异均有统计学意义,治疗组优于对照组(P<0.05)。2组间治疗后比较,血清铁(SI)、血清铁蛋白(SF)浓度及异常率差异有统计学意义,治疗组较对照组降低程度更显著、指标异常率更低(P<0.05)。组间治疗后比较,转铁蛋白(TRF)浓度及异常率差异有统计学意义,治疗组较对照组升高程度更显著、指标异常率更低(P<0.05)。3组间治疗后比较,治疗组丙氨酸氨基转移酶(ALT)水平较对照组降低更为明显,差异有统计学意义(P<0.05);乙肝表面抗原(HBs Ag)浓度差异有统计学意义,治疗组较对照组降低程度更显著(P<0.05);CD3^+水平及异常率差异有统计学意义,治疗组较对照组升高程度更显著、指标异常率更低(P<0.05);CD4^+/CD8^+异常率差异有统计学意义(P<0.05)。结论基于"伏邪"说的肝复安治疗慢乙肝患者铁代谢异常,能有效纠正铁代谢异常,恢复免疫功能,抑制病毒复制,减轻肝脏损伤。 Objective To observe the clinical effects of the "Ganfuan" decoction on the iron metabolism dysregulation in chronic viral hepatitis B patients based on Fuxie theory. Methods 102 HBV-infected patients( chronic hepatitis and liver cirrhosis) with abnormal iron metabolism were divided into the treatment group ( n = 48 ) treated with "Ganfuan" decoction , and control group ( n = 54 ) treated with conventional drugs ( antivirus, hepatoprotectants ), with a course of 36 months. The degree of iron deposition on liver, serum markers of iron metabolism, liver function, HBV level, immune cell counts and abnormal ratio were measured and compared. Results ①There was significant difference in hepatic iron deposition between the treatment group and control group on the 24th and 36th month (P 〈 0.05 ), and the treatment group was more effective. ②There were significant differences in concentration and abnormal ratio of SF, SI and TRF between the treatment and control group after 36 months ( P 〈 0.05 ). Compared with the control group, the degree of the SI, SF reduction in the treatment group was more significant and the abnormal rate was lower. ③There were significant differences in ALT, HBsAg, CD3^+ and abnormal ratio of CD3^+ and CD4^+/CD8^+ between the treatment and control group after treatment (P 〈 0.05) ,and the treatment group was more effective. Conclusion "Ganfuan" decoction based on Fuxie theory could rennrmalize the iron metabolism dysregulation effectively, recover the immune function, depress the virus replication, and alleviate the liver injury.
出处 《上海中医药杂志》 2016年第8期38-42,45,共6页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市卫生局中医药事业发展三年行动计划重大研究项目(ZYSNXD-CC-ZDYJ022) 上海市科委科研计划项目(1340190290A)
关键词 慢性乙型病毒性肝炎 肝脏铁过载 伏邪 肝复安 chronic hepatitis B liver iron overload Fuxie Ganfuan
  • 相关文献

参考文献21

  • 1Haresh M, David EK. Liver biopsy findings in chronic hepatitis B [ J ]. Hepatology ,2009,49 ( 5 Suppl) : S61 -S71.
  • 2Franchini M, Targher G, Capra F, et al. The effect of iron depletion on chronic hepatitis C virus infection [ J ]. Hepatol Int, 2008,2 (3): 335-340.
  • 3Chrobot A, Chrobot AM, Szaflarska-Szczepanik A. Assessment of iron metabolism in children with chronic hepatitis B-prognostic factor in interferon alpha therapy[ J ]. Med Sci Monit ,2001,8 ( 4 ) :269-275.
  • 4中华人民共和国卫生部传染病标准专业委员会.WS299-2008卫生行业标准“乙型病毒性肝炎诊断标准(2008)”[S].北京:人民卫生出版社,2009:1-2.
  • 5乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J].中华消化杂志,2014,34(2):77-84. 被引量:27
  • 6上海市卫生局.上海市中医病证诊疗常规[M].上海:上海中医药大学出版社,2005:455.
  • 7曹治宸,白玉,杨学农,刘金星,李兵顺,李凤林.乙型肝炎肝损伤中铁代谢异常的研究[J].中华肝脏病杂志,2001,9(1):37-39. 被引量:21
  • 8Blumberg BS. Serum ferriton as predictor of host response to hepatitis virus infection [ J]. Science, 1983,220(4595 ) :423-425.
  • 9Pipemo A, Vergani A. Hepatic iron overload in patients with chronieal viral hepatitis: role of HFE gene mutation [ J ]. Hepatology, 1998,28 (4) :1105-1109.
  • 10Lv W, Yan F ,Zeng M ,et al. Value of abdominal susceptibility weighted magnetic resonance imaging for quantitative assessment of hepatic iron deposition in patients with chronic hepatitis B:eomparison with serum iron markers[ J ]. JIMR,2012,40(3 ) : 1005-1015.

二级参考文献36

  • 1Olynyk J K,Gastroenterology,1995年,108卷,1104页
  • 2Batts KP. Iron overload syndromes and the liver [J]. Mod Pathol, 2007, 20: 31-39.
  • 3Fumtani T, Hino K, Okuda M, et al. Hepatic iron overload in- duces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein [J]. Gastroenterology, 2006, 130: 2087-2098.
  • 4Isom HC, MeDevitt EI, Moon MS. Elevated hepatic iron: a con- founding factor in chronic hepatitis C [J]. Biochim Biophys Acta, 2009, 1790: 650-662.
  • 5Fujita N, Sugimoto R, Takeo M, et al. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C [J]. Mol Med, 2007, 13: 97-104.
  • 6Christoforidis A, Haritandi A, Tsitouridis I, et al. Correlative study of iron accumulation in liver, myocardimn, and pituitary assessed with MRI in young thalassemie patients [J]. J Pediatr Hematol Oncol, 2006, 28: 311-315.
  • 7Nielsen P, Engelhardt R, Duerken M, et al. Using SQUID bio- magnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases[J]. Transfus Sci, 2000, 23: 257-258.
  • 8Kirk P, He TG. International Reproducibility of Single Breath- hold T* MR for Cardiac and Liver Iron Assessment Among Five Thalassemia Centers [J]. J Magn Reson Imaging, 2010, 32: 315-319.
  • 9Beaumont M. Accurate Liver T2* Measurement of Iron Overload: A Simulations Investigation and In Vivo Study[J]. J Magn Reson Imaging, 2009, 30: 313-320.
  • 10Maris TG, Papakonstantinou O, Chatzimanoli V, et al, Myocar- dial and Liver Iron Status Using a Fast T2* Quantitative MRI Technique[J]. Magn Reson Med, 2007, 57: 742-753.

共引文献50

同被引文献50

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部